Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Shanghai Pharmaceuticals: Sitagliptin Metformin Extended-Release Tablets Approved for Production
Shanghai Pharmaceuticals announced that its subsidiary, Changzhou Pharmaceutical Factory Co., Ltd., has received the “Drug Registration Certificate” (Certificate No.: 2026S00307) from the National Medical Products Administration, authorizing the production of Sitagliptin Metformin Extended-Release Tablets. Sitagliptin Metformin Extended-Release Tablets are indicated for adult patients with type 2 diabetes mellitus who are receiving combination therapy with sitagliptin and metformin extended-release tablets. This medication was originally developed by Merck Sharp & Dohme and was上市 in the United States in 2012.